A Relative Bioavailability Study of Rabeprazole Sodium Administered With Different Dosing Vehicles in Healthy Adult Volunteers

NCT01186497 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Rabeprazole sodium: Treatment E
DRUG: Rabeprazole sodium: Treatment C
DRUG: Rabeprazole sodium: Treatment D
DRUG: Rabeprazole sodium: Treatment A
DRUG: Rabeprazole sodium: Treatment B

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.